More evidence for use of pneumococcal conjugate vaccines

Affiliations

¹ Respiratory Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. cwhitney@cdc.gov

Comment

Cynthia G Whitney. Lancet. 2013.

. 2013 Jan 19;381(9862):182-3.

doi: 10.1016/S0140-6736(12)61957-6. Epub 2012 Nov 16.

¹ Respiratory Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. cwhitney@cdc.gov

No abstract available

Comment on

Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial.
Palmu AA, Jokinen J, Borys D, Nieminen H, Ruokokoski E, Siira L, Puumalainen T, Lommel P, Hezareh M, Moreira M, Schuerman L, Kilpi TM. Palmu AA, et al. Lancet. 2013 Jan 19;381(9862):214-22. doi: 10.1016/S0140-6736(12)61854-6. Epub 2012 Nov 16. Lancet. 2013. PMID: 23158882 Clinical Trial.